Fatema Abdulaal is a Senior Pharmacist at the National Health Regulatory Authority (NHRA) in the Kingdom of Bahrain, where she has served since 2021. She works within the Medicines Registration and Pricing group, contributing to a wide range of regulatory activities related to the evaluation and oversight of medicinal products. Her responsibilities include the scientific assessment of New Drug Applications (NDAs) and post-approval variations, as well as the classification of medicinal products and evaluation of classification and resubmission applications for alternative and complementary medicines.

Fatema currently leads the national pharmacovigilance initiative in Bahrain, overseeing the establishment and implementation of the country’s pharmacovigilance system. Her work includes developing regulatory frameworks, operational procedures, and reporting infrastructure to support effective monitoring of medicine safety and align national practices with international standards, including the WHO Programme for International Drug Monitoring.

Prior to joining NHRA, Fatema served at King Hamad University Hospital (KHUH) from 2014 as an inpatient pharmacist and later as a Quality and Safety Coordinator. During this time, she gained extensive experience in pharmacy practice, medication safety, healthcare quality improvement, and hospital regulatory compliance, contributing to initiatives aimed at enhancing patient safety and optimizing medication use.

Fatema holds a Bachelor of Science (BSc) in Pharmaceutical Sciences and a Master of Science (MSc) in Quality and Patient Safety in Healthcare Management from the Royal College of Surgeons in Ireland (RCSI). She is professionally committed to strengthening regulatory systems, advancing pharmacovigilance, and promoting medication safety and healthcare quality at the national level.